Institute for Protein Innovation
Samantha Singer is an Entrepreneur-in-Residence at Third Rock Ventures and President and CEO of Abata Therapeutics. She previously served as the Chief Operating Officer of the Broad Institute and, before that, was an executive at Biogen. Singer also served as an Independent Director on the Board for Rodin Therapeutics, until the company was acquired by Alkermes.
This person is not in the org chart
This person is not in any teams
Institute for Protein Innovation
The Institute for Protein Innovation is a 501(c)(3) non-profit that aims to reignite the field of protein science as a means to realize the promise of genomics to advance biology and promote human health.